Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7118)
All Articles published online
|
Publishing Process of This Article
|
Aug 10, 2014 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Crozier JA, Swaika A, Moreno-Aspitia A. Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines. World J Clin Oncol 2014; 5(3): 529-538 [PMID: 25114866 DOI: 10.5306/wjco.v5.i3.529] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i3/529.htm |
| Number | Citing Articles |
| 1 |
Bennett E Levis, Phillip F Binkley, Charles L Shapiro. Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?. The Lancet Oncology 2017; 18(8): e445 doi: 10.1016/S1470-2045(17)30535-1
|
| 2 |
Jonathan Cowman, Louis Richter, Roisin Walsh, Niamh Keegan, Willard Tinago, Antonio J. Ricco, Bryan T Hennessy, Dermot Kenny, Eimear Dunne. Dynamic platelet function is markedly different in patients with cancer compared to healthy donors. Platelets 2019; 30(6): 737 doi: 10.1080/09537104.2018.1513475
|
| 3 |
Yan Guo, Shuren Zhang, Hao Yuan, Dongfan Song, Suxing Jin, Zijian Guo, Xiaoyong Wang. A platinum(iv) prodrug to defeat breast cancer through disrupting vasculature and inhibiting metastasis. Dalton Transactions 2019; 48(11): 3571 doi: 10.1039/C9DT00335E
|
| 4 |
|
| 5 |
ROHIT R. BHOSALE, BHAGYESH U. JANUGADE, DHANASHRI D. CHAVAN, VANDANA M. THORAT. CURRENT PERSPECTIVES ON APPLICATIONS OF NANOPARTICLES FOR CANCER MANAGEMENT. International Journal of Pharmacy and Pharmaceutical Sciences 2023; : 1 doi: 10.22159/ijpps.2023v15i11.49319
|
| 6 |
Kejun Jiang, Xu Song, Liuqing Yang, Lin Li, Zhuoya Wan, Xun Sun, Tao Gong, Qing Lin, Zhirong Zhang. Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin. Journal of Controlled Release 2018; 271: 21 doi: 10.1016/j.jconrel.2017.12.026
|
| 7 |
Li Zhang, Yang Wang, Yuting Yang, Yayuan Liu, Shaobo Ruan, Qianyu Zhang, Xiaowei Tai, Jiantao Chen, Tai Xia, Yue Qiu, Huile Gao, Qin He. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer. ACS Applied Materials & Interfaces 2015; 7(18): 9691 doi: 10.1021/acsami.5b01473
|
| 8 |
Jordan Henderson, Paul Adams, Kimberly Barber. Factors Determining Anthracycline Use in Hormone Receptor Positive, Early-Stage Breast Cancer. Clinical Breast Cancer 2019; 19(3): e475 doi: 10.1016/j.clbc.2019.01.012
|
| 9 |
Fatma Kubra Ata, Serap Yalcin. The Cisplatin, 5-fluorouracil, Irinotecan, and Gemcitabine Treatment in Resistant 2D
and 3D Model Triple Negative Breast Cancer Cell Line: ABCG2 Expression Data. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(2): 371 doi: 10.2174/1871520621666210727105431
|
| 10 |
Sepehr Darvishan, Mehrab Pourmadadi, Majid Abdouss, Saeedeh Mazinani, Fatemeh Yazdian, Abbas Rahdar, Ana M. Díez-Pascual. Gamma alumina coated-PAA/PVP hydrogel as promising quercetin nanocarrier: Physiochemical characterization and toxicity activity. Journal of Drug Delivery Science and Technology 2023; 84: 104500 doi: 10.1016/j.jddst.2023.104500
|
| 11 |
Manpreet Sambi, Bessi Qorri, William Harless, Myron R. Szewczuk. Breast Cancer Metastasis and Drug Resistance. Advances in Experimental Medicine and Biology 2019; 1152: 131 doi: 10.1007/978-3-030-20301-6_8
|
| 12 |
Sheng-Miauh Huang, Ling-Ming Tseng, Li-Yin Chien, Chen-Jei Tai, Ping-Ho Chen, Chia Tai Hung, Yvonne Hsiung. Effects of non-sporting and sporting qigong on frailty and quality of life among breast cancer patients receiving chemotherapy. European Journal of Oncology Nursing 2016; 21: 257 doi: 10.1016/j.ejon.2015.10.012
|
| 13 |
Ruth Ronn, Hananel Holzer. Breast cancer and fertility. Current Opinion in Supportive & Palliative Care 2015; 9(3): 285 doi: 10.1097/SPC.0000000000000164
|
| 14 |
Ping-Ho Chen, Sheng-Miauh Huang, Chen-Jei Tai, Li-Yin Chien, Pei-Ju Lien, Yu-Hsien Chen. Meditative qigong relieved symptom severity and interference among patients with breast carcinoma receiving chemotherapy. European Journal of Integrative Medicine 2015; 7(6): 617 doi: 10.1016/j.eujim.2015.08.010
|
| 15 |
Umme Hani, Mohamed Rahamathulla, Riyaz Ali Osmani, Honnavalli Yogish Kumar, Deeparani Urolagin, Mohammad Yousuf Ansari, Kamal Pandey, Keerthana Devi, Sabina Yasmin. Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review. Journal of Drug Delivery Science and Technology 2020; 56: 101505 doi: 10.1016/j.jddst.2020.101505
|
| 16 |
Letícia Stefenon, Marcos Boasquevisque, Aguinaldo Silva Garcez, Vera Cavalcanti de Araújo, Andresa Borges Soares, Alan Roger Santos-Silva, Felipe Sperandio, Juliana Mançano Melhado Brod, Marcelo Sperandio. Autophagy upregulation may explain inhibition of oral carcinoma in situ by photobiomodulation in vitro. Journal of Photochemistry and Photobiology B: Biology 2021; 221: 112245 doi: 10.1016/j.jphotobiol.2021.112245
|
| 17 |
Antonio Palumbo, Nathalia de Oliveira Meireles Da Costa, Martin Hernan Bonamino, Luis Felipe Ribeiro Pinto, Luiz Eurico Nasciutti. Genetic instability in the tumor microenvironment: a new look at an old neighbor. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0409-y
|
| 18 |
Rabia Kouser, Arti Vashist, Mohammed Zafaryab, Moshahid A. Rizvi, Sharif Ahmad. pH-Responsive Biocompatible Nanocomposite Hydrogels for Therapeutic Drug Delivery. ACS Applied Bio Materials 2018; 1(6): 1810 doi: 10.1021/acsabm.8b00260
|
| 19 |
Konstantinos D. Dinas. Diseases of the Breast during Pregnancy and Lactation. Advances in Experimental Medicine and Biology 2020; 1252: 175 doi: 10.1007/978-3-030-41596-9_24
|
| 20 |
Amy A. Kirkham, Rhys I. Beaudry, D. Ian Paterson, John R. Mackey, Mark J. Haykowsky. Curing breast cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer. Progress in Cardiovascular Diseases 2019; 62(2): 116 doi: 10.1016/j.pcad.2019.02.002
|
| 21 |
Jiehua Ma, Hai Shi, Meiling Zhang, Chao Li, Yang Xiang, Ping Liu. A homogeneous, Anti-dsDNA antibody-based assay for multicolor detection of cancer stem cell transcription factors. Analytica Chimica Acta 2018; 1029: 72 doi: 10.1016/j.aca.2018.04.060
|
| 22 |
Fengzhu Guo, Zongbi Yi, Wenna Wang, Yiqun Han, Pei Yu, Su Zhang, Quchang Ouyang, Min Yan, Xiaojia Wang, Xichun Hu, Zefei Jiang, Tao Huang, Zhongsheng Tong, Shusen Wang, Yongmei Yin, Hui Li, Runxiang Yang, Huawei Yang, Yuee Teng, Tao Sun, Li Cai, Hongyuan Li, Xi Chen, Jianjun He, Xinlan Liu, Shune Yang, Jinhu Fan, Youlin Qiao, Jiayu Wang, Binghe Xu. Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study. Cancer Medicine 2021; 10(19): 6744 doi: 10.1002/cam4.4215
|
| 23 |
P.-L. Hsieh, S.-M. Huang, L.-Y. Chien, C.-F. Lee, Y. Hsiung, C.-J. Tai. Risk-benefit perception of pregnancy among breast cancer survivors. European Journal of Cancer Care 2018; 27(2): e12696 doi: 10.1111/ecc.12696
|
| 24 |
Tai Xia, Qin He, Kairong Shi, Yang Wang, Qianwen Yu, Li Zhang, Qianyu Zhang, Huile Gao, Lifang Ma, Ji Liu. Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer. Pharmaceutical Development and Technology 2018; 23(1): 13 doi: 10.1080/10837450.2016.1265553
|
| 25 |
Judith Strickland, Carla Foley Wells, Caroline Porr. Safeguarding the Children: The Cancer Journey of Young Mothers. Oncology Nursing Forum 2015; 42(5): 534 doi: 10.1188/15.ONF.534-541
|
| 26 |
Kirsten A. Nyrop, Allison M. Deal, Shlomit S. Shachar, Ethan Basch, Bryce B. Reeve, Seul Ki Choi, Jordan T. Lee, William A. Wood, Carey K. Anders, Lisa A. Carey, Elizabeth C. Dees, Trevor A. Jolly, Katherine E. Reeder-Hayes, Gretchen G. Kimmick, Meghan S. Karuturi, Raquel E. Reinbolt, JoEllen C. Speca, Hyman B. Muss. Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer. The Oncologist 2019; 24(6): 762 doi: 10.1634/theoncologist.2018-0590
|
| 27 |
Juanjuan Zhang, Hiroaki Kinoh, Louise Hespel, Xueying Liu, Sabina Quader, John Martin, Tsukasa Chida, Horacio Cabral, Kazunori Kataoka. Effective treatment of drug resistant recurrent breast tumors harboring cancer stem-like cells by staurosporine/epirubicin co-loaded polymeric micelles. Journal of Controlled Release 2017; 264: 127 doi: 10.1016/j.jconrel.2017.08.025
|
| 28 |
Zhi‐Jun Huo, Shi‐Jiang Wang, Zhi‐Qi Wang, Wen‐Shu Zuo, Ping Liu, Bo Pang, Kai Liu. Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation. Cancer Science 2015; 106(10): 1429 doi: 10.1111/cas.12737
|
| 29 |
Jessica E. Pullan, Matthew I. Confeld, Jenna K. Osborn, Jiha Kim, Kausik Sarkar, Sanku Mallik. Exosomes as Drug Carriers for Cancer Therapy. Molecular Pharmaceutics 2019; 16(5): 1789 doi: 10.1021/acs.molpharmaceut.9b00104
|
| 30 |
Arielle S Gillman, Jacqueline B Vo, Anju Nohria, Rebecca A Ferrer. Decision Science Can Inform Clinical Trade-Offs Regarding Cardiotoxic Cancer Treatments. JNCI Cancer Spectrum 2021; 5(4) doi: 10.1093/jncics/pkab053
|
| 31 |
Geetika Chakravarty, Aditi Mathur, Pallavi Mallade, Samantha Gerlach, Joniece Willis, Amrita Datta, Sudesh Srivastav, Asim B. Abdel-Mageed, Debasis Mondal. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells. Biochimie 2016; 124: 53 doi: 10.1016/j.biochi.2016.01.014
|
| 32 |
Che Fu Liu, Raymond Chen, Joseph A. Frezzo, Priya Katyal, Lindsay K. Hill, Liming Yin, Nikita Srivastava, Haresh T. More, P. Douglas Renfrew, Richard Bonneau, Jin Kim Montclare. Efficient Dual siRNA and Drug Delivery Using Engineered Lipoproteoplexes. Biomacromolecules 2017; 18(9): 2688 doi: 10.1021/acs.biomac.7b00203
|
| 33 |
Jennifer A. Crozier, Pooja P. Advani, Betsy LaPlant, Timothy Hobday, Anthony J. Jaslowski, Alvaro Moreno-Aspitia, Edith A. Perez. N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy. Clinical Breast Cancer 2016; 16(1): 23 doi: 10.1016/j.clbc.2015.08.002
|
| 34 |
Marta Hergueta-Redondo, David Sarrio, Ángela Molina-Crespo, Rocío Vicario, Cristina Bernadó-Morales, Lidia Martínez, Alejandro Rojo-Sebastián, Jordi Serra-Musach, Alba Mota, Ángel Martínez-Ramírez, Maria Ángeles Castilla, Antonio González-Martin, Sonia Pernas, Amparo Cano, Javier Cortes, Paolo G. Nuciforo, Vicente Peg, José Palacios, Miguel Ángel Pujana, Joaquín Arribas, Gema Moreno-Bueno. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer. Oncotarget 2016; 7(35): 56295 doi: 10.18632/oncotarget.10787
|
| 35 |
Kyle McIntosh, Curt Balch, Amit K. Tiwari. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells. Expert Opinion on Drug Metabolism & Toxicology 2016; 12(6): 633 doi: 10.1080/17425255.2016.1179280
|
| 36 |
Fernando Alarid-Escudero, Anne H. Blaes, Karen M. Kuntz. Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter?. The Breast Journal 2017; 23(4): 401 doi: 10.1111/tbj.12757
|
| 37 |
Hui Xie, Jinping Liu, Shiyou Yu, Yiding Chen, Min Zheng, Yongchuan Deng, Shu Wang, Jun Jiang, Yafen Li, Huiping Li, Hua Kang, Chunhui Zhang, Guo-Jun Zhang, Fengxi Su, Aiqun Cheng, Shui Wang. Patterns of Use of Docetaxel-Containing Adjuvant Chemotherapy Among Chinese Patients with Operable Breast Cancer: A Multicenter Observational Study. Advances in Therapy 2019; 36(1): 131 doi: 10.1007/s12325-018-0841-7
|
| 38 |
Lina Wu, Lu Yao, Hong Zhang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, C. Cameron Yin, Yuntao Xie. A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Oncotarget 2016; 7(4): 5042 doi: 10.18632/oncotarget.5837
|
| 39 |
Giuseppe Curigliano, Daniela Cardinale, Susan Dent, Carmen Criscitiello, Olexiy Aseyev, Daniel Lenihan, Carlo Maria Cipolla. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management. CA: A Cancer Journal for Clinicians 2016; 66(4): 309 doi: 10.3322/caac.21341
|
| 40 |
Quynh Hoa Tran, Dang Hieu Hoang, Minhyeok Song, Wonchae Choe, Insug Kang, Sung Soo Kim, Joohun Ha. Melatonin and doxorubicin synergistically enhance apoptosis via autophagy-dependent reduction of AMPKα1 transcription in human breast cancer cells. Experimental & Molecular Medicine 2021; 53(9): 1413 doi: 10.1038/s12276-021-00675-y
|
| 41 |
Fu Ou Yang, Nicholas C. Hsu, Sin‐Hua Moi, Yin‐Che Lu, Chia‐Ming Hsieh, King‐Jen Chang, Dar‐Ren Chen, Chi‐Wen Tu, Hwei‐Chung Wang, Ming‐Feng Hou. Efficacy and toxicity of pegylated liposomal doxorubicin‐based chemotherapy in early‐stage breast cancer: a multicenter retrospective case–control study. Asia-Pacific Journal of Clinical Oncology 2018; 14(3): 198 doi: 10.1111/ajco.12771
|
| 42 |
John J. Atherton, Andrew Sindone, Carmine G. De Pasquale, Andrea Driscoll, Peter S. MacDonald, Ingrid Hopper, Peter M. Kistler, Tom Briffa, James Wong, Walter Abhayaratna, Liza Thomas, Ralph Audehm, Phillip Newton, Joan O'Loughlin, Maree Branagan, Cia Connell. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018. Heart, Lung and Circulation 2018; 27(10): 1123 doi: 10.1016/j.hlc.2018.06.1042
|
| 43 |
Deborah A. Boyle. Cancer and the Broken Heart. Journal of Infusion Nursing 2018; 41(4): 229 doi: 10.1097/NAN.0000000000000285
|
| 44 |
Selamawit Dagne, Sefinew Migbaru Abate, Wondemagegnhu Tigeneh, Ephrem Engidawork. Assessment of breast cancer treatment outcome at Tikur Anbessa Specialized Hospital Adult Oncology Unit, Addis Ababa, Ethiopia. European Journal of Oncology Pharmacy 2019; 2(2): e13 doi: 10.1097/OP9.0000000000000013
|
| 45 |
Amy A. Kirkham, Neil D. Eves, Rob E. Shave, Kelcey A. Bland, Joshua Bovard, Karen A. Gelmon, Sean A. Virani, Don C. McKenzie, Eric J. Stöhr, Darren E. R. Waburton, Kristin L. Campbell. The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT. Breast Cancer Research and Treatment 2018; 167(3): 719 doi: 10.1007/s10549-017-4554-4
|